The OBIO® Capital Access Advisory Program (CAAP®) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. OBIO’s CAAP® creates high value deal flow for both companies and investors, and opportunity to participate at the OBIO® Investment Summit and other international investment conferences.

What is OBIO’s CAAP®?

A competitive, 9-12 month structured program for health science companies starting to prepare and raise Series A financing over the next year.
CAAP® covers three fundamental business themes:

Business strategic planning & increasing the ROI for investors
Advanced fundraising strategies & financial modeling
Closing an investment round and business development contract

Benefits for CAAP® companies:

Strategic Connections: Receive warm introductions and strategic guidance to venture investors, healthcare executives and business experts customized to your business strategy

Lead Generation: Leverage support from the OBIO® team to reach out to VCs and strategic partners at international conferences to generate new leads
Valuable Network Access: Get connected with the CAAP® and EAHN® alumni network of founders, as well as executive teams from OBIO® companies that have successfully closed financing
Continuous Support: Enjoy ongoing support throughout your company’s journey, become a CAAP® alumnus